In March, Cognixion announced a clinical trial with late-stage ALS patients. Axon-R, which leading brain-computer interface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback